ImranNSiddiqiMD
Pathology • Los Angeles, CAHematopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology, USC School of Medicine
Dr. Siddiqi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2011 Zonal Ave
Hmr 209
Los Angeles, CA 90089Phone+1 323-226-2698Fax+1 323-226-2686- Is this information wrong?
Summary
- Dr. Imran Siddiqi is a pathologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, Los Angeles Community Hospital at Los Angeles, and USC Norris Comprehensive Cancer Center. He received his medical degree from University of California Irvine School of Medicine and has been in practice 15 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.
Education & Training
University of California (San Francisco)Fellowship, Hematopathology, 2006 - 2007- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2002 - 2006
University of California, Irvine, School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- How I diagnose and manage VEXAS syndrome.Ashley Hagiya, Imran N Siddiqi, Endi Wang, Chuanyi M Lu> ;American Journal of Clinical Pathology. 2024 Mar 21
- 1 citationsChronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplas...Yue Zhao, Imran Siddiqi, Tyler J Wildes, Jenna McCracken, Kristen Deak, Catherine Rehder, Endi Wang> ;American Journal of Clinical Pathology. 2023 Apr 4
- 1 citationsGut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.Ahmed Rokan, Juan Carlos Hernandez, Rajeshwar Nitiyanandan, Zi-Ying Lin, Chia-Lin Chen, Tatsuya Machida, Meng Li, Jasleen Khanuja, Mo Li Chen, Stanley M Tahara, Imran ...> ;Molecular Cancer Research. 2023 Feb 1
- Join now to see all
Press Mentions
Deadliest Cancers May Respond to New Drug Treatment StrategyJanuary 29th, 2016
Hospital Affiliations
Keck Hospital of USCLos Angeles, California- Los Angeles Community Hospital at Los AngelesLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
